Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)

被引:127
|
作者
Maltezou, H. C. [1 ]
Giakkoupi, P. [2 ]
Maragos, A. [1 ]
Bolikas, M. [3 ]
Raftopoulos, V. [1 ]
Papahatzaki, H. [3 ]
Vrouhos, G. [4 ]
Liakou, V. [3 ]
Vatopoulos, A. C. [2 ]
机构
[1] Hellen Ctr Dis Control & Prevent, Dept Intervent Health Care Facil, Athens, Greece
[2] Natl Sch Publ Hlth, Dept Microbiol, Athens, Greece
[3] Venizeleio Gen Hosp, Dept Microbiol, Iraklion, Greece
[4] Venizeleio Gen Hosp, Intens Care Unit, Iraklion, Greece
关键词
KPC; Carbapenemase; Resistance; Nosocomial outbreak; Klebsiella pneumoniae; Tigecycline; Colistin; HYDROLYZING BETA-LACTAMASE; KPC-2; ISOLATE; TIGECYCLINE; SPP;
D O I
10.1016/j.jinf.2009.01.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Starting in May 2007, an ongoing outbreak of infections due to carbapenem resistant KPC-2-producing Klebsiella pneumoniae occurred in a tertiary care hospital in Crete (Greece). The outbreak involved 22 patients, none of whom had travelled in a country with known high prevalence of such isolates. KPC-producing K. pneumoniae strains were mainly isolated from patients admitted in the Intensive Care Unit, on mechanical ventilation, with prolonged hospitalization, prolonged administration of antibiotics, and prolonged administration of carbapenems. Clinical diagnoses were: pneumonia (62% of cases), surgical site infection (19%), bacteremia (9.5%), urinary tract infection (4.7%), and peritonitis (4.7%). Overall, 61 KPC-producing K. pneumoniae isolates were recovered, mainly from the respiratory tract (59.1%), catheter tip (22.7%), surgical site (18.2%), and blood (18.2%). Among 16 patients for whom therapeutic data were available, 14 (87.5%) were treated with a combination of colistin and/or tigecycline and/or garamycin. Clinical failure was noted in 22.2% of 18 patients available for assessment of clinical outcome, and microbiologic failure in 87.5% of 8 patients available for assessment of microbiologic outcome. In conclusion, an outbreak of KPC-producing K. pneumoniae infections has occurred in a tertiary care hospital in Greece, with significant associated morbidity and mortality. Prospective studies are required to evaluate the available therapeutic options for these infections. Our efforts should focus on rational use of available antibiotics, enhancement of infection control measures, and implementation of active antibiotic resistance surveillance. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 50 条
  • [21] Outbreak of Klebsiella pneumoniae producing KPC-2 and SHV-12 in a French hospital
    Kassis-Chikhani, Najiby
    Decre, Dominique
    Ichai, Philippe
    Sengelin, Christian
    Geneste, Delphine
    Mihaila, Liliana
    Dussaix, Elisabeth
    Arlet, Guillaume
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (07) : 1539 - 1540
  • [22] Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland
    Morris, Dearbhaile
    Boyle, Fiona
    Morris, Carol
    Condon, Iris
    Delannoy-Vieillard, Anne-Sophie
    Power, Lorraine
    Khan, Aliya
    Morris-Downes, Margaret
    Finnegan, Cathriona
    Powell, James
    Monahan, Regina
    Burns, Karen
    O'Connell, Nuala
    Boyle, Liz
    O'Gorman, Alan
    Humphreys, Hilary
    Brisse, Sylvain
    Turton, Jane
    Woodford, Neil
    Cormican, Martin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (10) : 2367 - 2372
  • [23] Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin
    Kontopoulou, K.
    Protonotariou, E.
    Vasilakos, K.
    Kriti, M.
    Koteli, A.
    Antoniadou, E.
    Sofianou, D.
    JOURNAL OF HOSPITAL INFECTION, 2010, 76 (01) : 70 - 73
  • [24] Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs
    Hagihara, Mao
    Crandon, Jared L.
    Urban, Carl
    Nicolau, David P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (07) : 1616 - 1618
  • [25] Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China
    Liu, Jingxian
    Yu, Jing
    Chen, Feng
    Yu, Jiajia
    Simner, Patricia
    Tamma, Pranita
    Liu, Ying
    Shen, Lisong
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (02) : 293 - 299
  • [26] Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China
    Jingxian Liu
    Jing Yu
    Feng Chen
    Jiajia Yu
    Patricia Simner
    Pranita Tamma
    Ying Liu
    Lisong Shen
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 293 - 299
  • [27] Outbreak of KPC-2-Producing Klebsiella pneumoniae ST76 Isolates in an Intensive Care Unit and Neurosurgery Unit
    Su, Shanshan
    Li, Chunjiang
    Zhao, Yongxin
    Yu, Lan
    Wang, Yong
    Wang, Yuchao
    Bao, Mingjia
    Fu, Yu
    Zhang, Jisheng
    Zhang, Xiaoli
    MICROBIAL DRUG RESISTANCE, 2020, 26 (09) : 1009 - 1018
  • [28] Genomic analysis of the first isolate of KPC-2-producing Klebsiella pneumoniae from Uruguay
    Alvarez, Veronica E.
    Campos, Josefina
    Galiana, Antonio
    Borthagaray, Graciela
    Centron, Daniela
    Marquez Villalba, Carolina
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 15 : 109 - 110
  • [29] Genetic diversity of KPC-2-producing Klebsiella pneumoniae complex from aquatic ecosystems
    Rosa, Rafael da Silva
    Furlan, Joao Pedro Rueda
    Santos, Lucas David Rodrigues dos
    Ramos, Micaela Santana
    Savazzi, Eduardo Angelino
    Stehling, Eliana Guedes
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2024, 40 (06):
  • [30] Epidemiology of Klebsiella pneumoniae carbapenemase (KPC) producing Klebsiella pneumoniae in a German hospital
    Wendt, C.
    Schuett, S.
    Dalpke, A.
    Zimmermann, S.
    Trierweiler-Hauke, B.
    Konrad, M.
    Mieth, M.
    Weigand, M.
    Hoppe-Tichy, T.
    Jonas, D.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 : 34 - 35